ElectromedELMD +3.52%91 Days Payable is 57.03 as of Mar. 2026, which is 52% above its 10-year median of 37.50. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.16 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Electromed ranks worse than 58.99% on this metric.
Electromed's average Accounts Payable for the
three
months ended in Mar. 2026 was $2.46 Mil. Electromed's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $3.93 Mil.
Hence, Electromed's Days Payable for the
three
months ended in Mar. 2026 was 57.03.
The historical rank and industry rank for Electromed's Days Payable or its related term are showing as below:
ELMD'
s Days Payable Range Over the Past 10 Years
Min: 26.8 Med: 37.5 Max: 59.46
Current: 59.46
During the past 13 years, Electromed's highest Days Payable was 59.46. The lowest was 26.80. And the median was 37.50.
ELMD's Days Payable is ranked worse than 58.99% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs ELMD: 59.46
Electromed's Days Payable
increased
from Mar. 2025 (44.70) to Mar. 2026 (57.03).
It may suggest that Electromeddelayed paying its suppliers.
Electromed Days Payable Related Terms
Electromed Days Payable Historical Data
* Premium members only.
The historical data trend for Electromed's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Electromed's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Electromed Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Days Payable distribution charts can be found below:
* The bar in red indicates where Electromed's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Electromed's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Electromed (ELMD) has a Days Payable of 57.03 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Electromed and its competitors. This is 52% above median its historical median of 37.50. Over the past decade, Electromed's Days Payable has ranged from 26.80 to 59.46. According to the industry distribution chart, Electromed ranks #469 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 59%.
Is Electromed's Days Payable too high?
Electromed's current Days Payable of 57.03 is 52% above median its 10-year median of 37.50. Over the past 10 years, this metric has ranged from a low of 26.80 to a high of 59.46. The Medical Devices & Instruments industry median Days Payable is 67.87. Electromed's value of 57.03 is 16% below this industry median. Based on the distribution chart, Electromed ranks #469 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Days Payable compare to MASS and SI?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #469 out of 795 companies for Days Payable. This places Electromed in the lower half of its industry. The industry median Days Payable is 67.87. Electromed's value of 57.03 is 16% below this benchmark. Historically, Electromed's own Days Payable has ranged from 26.80 to 59.46 over the past decade. While the company's 10-year median is 37.50 vs. the industry median of 67.87, Electromed has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Electromed's current Days Payable of 57.03 is 16% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Electromed and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Electromed's current Days Payable is 57.03, which is 52% above median its own 10-year median of 37.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.16, compared to a current price of $41.46 — trading 64.8% above its estimated fair value. The current Days Payable is 57.03, which is 52% above median its 10-year median of 37.50 and 16% below the Medical Devices & Instruments industry median of 67.87. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Electromed (ELMD), the current Days Payable is 57.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Electromed (ELMD) Overvalued in 2026?
Based on GuruFocus' analysis, Electromed stock appears to be overvalued.
The current stock price of $41.46 is trading 64.8% above its estimated GF Value™ of $25.16.
GuruFocus considers Electromed to be Significantly Overvalued.
Key valuation signals for ELMD:
Days Payable: 57.03 (52% above median its 10-year median of 37.50)
GF Value™: $25.16 vs. price of $41.46 (64.8% above fair value)
Industry Position: 16% below the Medical Devices & Instruments median (#469 of 795)
No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score
Get the complete analysis for ELMD
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELMD has been successfully added to your 
